Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Imed Infinity Medical LPXTAE:IMED 18 EBIT per Share is ₪ as of . 20. GuruFocus rates XTAE:IMED with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 523 Healthcare Providers & Services companies, Imed Infinity Medical LP ranks worse than 191204.4% on this metric.
Imed Infinity Medical LP's EBIT per Share for the
six
months ended in . 20 was ₪0.00.
Imed Infinity Medical LP does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in . 20.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Imed Infinity Medical LP's EBIT per Share or its related term are showing as below:
XTAE:IMED's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.8 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Imed Infinity Medical LP (XTAE:IMED) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Imed Infinity Medical LP EBIT per Share Related Terms
Imed Infinity Medical LP EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imed Infinity Medical LP (XTAE:IMED) has a EBIT per Share of ₪ as of . 20. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Imed Infinity Medical LP and its competitors. According to the industry distribution chart, Imed Infinity Medical LP ranks #999999 out of 523 companies in the Healthcare Providers & Services industry.
Is Imed Infinity Medical LP's EBIT per Share too high?
Imed Infinity Medical LP's current EBIT per Share is ₪. Based on the distribution chart, Imed Infinity Medical LP ranks #999999 out of 523 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Imed Infinity Medical LP has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Imed Infinity Medical LP's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imed Infinity Medical LP ranks #999999 out of 523 companies for EBIT per Share. This places Imed Infinity Medical LP in the lower half of its industry. The industry median EBIT per Share is 11.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Imed Infinity Medical LP and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imed Infinity Medical LP's current EBIT per Share is ₪. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imed Infinity Medical LP stock overvalued right now?
Imed Infinity Medical LP (XTAE:IMED) has a current EBIT per Share of ₪. The current EBIT per Share is ₪. Imed Infinity Medical LP's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Imed Infinity Medical LP (XTAE:IMED), the current EBIT per Share is ₪ as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:IMED has been successfully added to your 
